HucMSCs

human umbilical cord mesenchymal stem cells · Tasly Pharmaceutical Group Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HucMSCs, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure [Phase 1, Phase 2]

See pricing